Stockholm - Delayed Quote SEK

Diagonal Bio AB (publ) (DIABIO.ST)

Compare
0.0258 +0.0013 (+5.31%)
At close: December 20 at 5:02:45 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
23.0000
23.0000
203.0000
407.0000
Cost of Revenue
-1,787.0000
-3,110.0000
-1,851.0000
492.0000
Gross Profit
1,810.0000
3,133.0000
2,054.0000
-85.0000
Operating Expense
12,723.0000
14,700.0000
17,217.0000
11,578.0000
Operating Income
-10,913.0000
-11,567.0000
-15,163.0000
-11,663.0000
Net Non Operating Interest Income Expense
-704.1000
-112.0000
-1,001.0000
--
Pretax Income
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Net Income Common Stockholders
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Diluted NI Available to Com Stockholders
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Basic EPS
-0.17
-0.32
-1.03
-1.03
Diluted EPS
-0.17
-0.32
-1.03
-1.03
Basic Average Shares
99,193.7190
36,478.4900
15,675.3770
11,346.7230
Diluted Average Shares
99,193.7190
36,478.4900
15,675.3770
11,346.7230
Total Operating Income as Reported
-10,912.0000
-11,566.0000
-15,163.0000
-11,663.0000
Total Expenses
10,936.0000
11,590.0000
15,366.0000
12,070.0000
Net Income from Continuing & Discontinued Operation
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Normalized Income
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Interest Income
85.9000
94.0000
--
--
Interest Expense
790.0000
206.0000
1,001.0000
--
Net Interest Income
-704.1000
-112.0000
-1,001.0000
--
EBIT
-10,826.0000
-11,472.0000
-15,163.0000
-11,663.0000
EBITDA
-10,467.0000
-11,469.0000
-15,163.0000
-11,663.0000
Reconciled Cost of Revenue
-1,787.0000
-3,110.0000
-1,851.0000
492.0000
Reconciled Depreciation
359.0000
3.0000
--
--
Net Income from Continuing Operation Net Minority Interest
-11,616.0000
-11,678.0000
-16,164.0000
-11,663.0000
Normalized EBITDA
-10,467.0000
-11,469.0000
-15,163.0000
-11,663.0000
12/31/2021 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
 
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
 
MODTX.ST Modus Therapeutics Holding AB (publ)
1.9000
-4.76%
 
ACTI.ST Active Biotech AB (publ)
0.1118
-2.10%
 
LIDDS.ST LIDDS AB (publ)
0.1045
-0.95%
 
CRNA.OL Circio Holding ASA
0.7080
-3.28%
 
ALTE.ST Alteco Medical AB
0.2280
+15.15%
 
ABERA.ST Abera Bioscience AB
4.1500
+3.75%
 
65G.F NextCell Pharma AB
0.1855
+9.12%
 
ONCOZ.ST OncoZenge AB (publ)
4.0000
+1.01%